2023-510263-35-00已完成1 期
A study in healthy men to test whether zongertinib influences the amount of 3 other medicines in the blood
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 16
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
CT Disclosure & Data Transparency
Scientific
Boehringer Ingelheim International GmbH
研究点 (1)
Loading locations...
相似试验
招募中
2 期
Zasocitinib in Nonsegmental Vitiligo2025-522309-40-00Takeda Development Center Americas Inc.32
招募中
2 期
Zanubritnib and anti-MAG neuropathy2025-523091-23-00Azienda Ospedaliera di Padova50
已完成
1 期
A study in healthy men to test how different doses of BI 3000202 are tolerated and how food influences the amount of BI 3000202 in the blood2022-502424-43-00Boehringer Ingelheim International GmbH68
已完成
1 期
A study in healthy men to test whether carbamazepine influences the amount of BI 1810631 in the blood2022-503046-50-00Boehringer Ingelheim International GmbH16
暂停
1 期
A study in healthy men to test how BI 1839100 is taken up and handled by the body2024-510870-26-00Boehringer Ingelheim International GmbH16